
Professor @VAInstitute. Chromatin biochemistry, cancer epigenetics, functional proteomics.
Grand Rapids, MI
Joined November 2018
- Tweets261
- Following255
- Followers621
- Likes717
Scott Rothbart retweeted
Big day for the David lab! 🎉 Our @MolecularCell paper is out today- huge congrats to first authors @IfeAkano & Jake Hebert for leading this beautiful study uncovering SMARCA3 as a novel H3 E3 ligase that shapes heterochromatin regulation in colorectal cancer 🤩
Online Now: The SWI/SNF-related protein SMARCA3 is a histone H3K23 ubiquitin ligase that regulates H3K9me3 in cancer dlvr.it/TLz0Lw
Scott Rothbart retweeted
A person’s lifetime risk for #cancer may begin before they are even born, reports a paradigm-shifting study by Van Andel Institute scientists published in @NatureCancer. @PospisilikJ @Bi0lilla vai.org/cancer-risk-developm…
Scott Rothbart retweeted
Thrilled to share the results @Cancer_Cell of years of hard work to develop classifiers for all major TCGA cancer subtypes, enabling assessment of differential drug response among cancer subtypes in clinical trials. cell.com/cancer-cell/fulltex…
Scott Rothbart retweeted
We have postdoc positions open to study epigenetic mechanisms contributing to resistance to chemo+immuno in TNBC, and projects related to epigenetic determinants of neurodevelopmental disorders. Feel free to reach out to me here/via email. Please like and repost!
Scott Rothbart retweeted
Congratulations to Van Andel Institute’s Dr. Peter Jones, VAI and @HopkinsKimmel's Dr. Stephen Baylin, and @HopkinsMedicine's Dr. Andrew Feinberg, who will receive the Harvey Prize for their groundbreaking work in cancer epigenetics! Read more: vai.org/harvey-prize
Scott Rothbart retweeted
Online Now: DNA hypomethylation promotes UHRF1-and SUV39H1/H2-dependent crosstalk between H3K18ub and H3K9me3 to reinforce heterochromatin states dlvr.it/TGZ732
Scott Rothbart retweeted
Congratulations to the authors @RothbartLab, shows the role of UHRF1 in the redistribution of H3K9me3 following DNA hypomethylation, a lingering question in the field and may have implications for the field of aging.
cell.com/molecular-cell/full…
Scott Rothbart retweeted
Time to move. See you all on Bluesky: @helink.bsky.social
Let's work on getting our respective institutions and our colleagues to move as well. There is an exponential increase in members on Bluesky!!
theguardian.com/media/2024/n…
Scott Rothbart retweeted
If you are interested in a faculty position in the heart of metabolism, at one of strongest and most supportive institutes focused on metabolism, epigenetics, neurodegeneration and more, VAI is recruiting at all levels! vai.wd1.myworkdayjobs.com/en…
Scott Rothbart retweeted
Great place to post doc @VAInstitute
This Post is from an account that no longer exists. Learn more
Scott Rothbart retweeted
Just 2 postdocs from @DrBrianStrahl’s lab (current: me; former: @RothbartLab) with their mentor. Looking forward to joining Scott on the former postdoc/current PI list by the next #BioMethylSRC
Scott Rothbart retweeted
Registration is still open for this super exciting meeting!
⭐️Unbelievable lineup of #epigenetics & #aging speakers
⭐️Opportunities for short talks
⭐️New pre-meeting dedicated to trainees w/ extra opportunities for career development & 1:1 with PIs
⭐️Special awards available!
Excited to be organizing my first international conference w/@petertessarz @TheWebbLab & @Morrison_Lab_SU on #epigenetic & #aging & everything in between!
Amazing speakers (keynotes @BrunetLab @MAF_Dawson @OdedRechavi) & a new opportunity for trainees⬇️
events.faseb.org/event/a7662…
Scott Rothbart retweeted
A pair of medications that make malignant cells act as if they have a virus could hold promise for treating #colorectalcancer & other solid tumors, according to a new preclinical study by scientists @RothbartLab.
#ColorectalCancerAwarenessMonth
vai.org/rothbart-crc-study
Scott Rothbart retweeted
"The unmet potential of DNA methyltransferase inhibition therapy in patients with solid tumors underscores the importance of our findings."
Congrats to @AmericanCancer grantee @RothbartLab for this this exciting study as we come to the end of #ColorectalCancerAwarenessMonth!
New paper from the lab reveals a link between epigenetic therapy-induced viral mimicry and NFAT:AP1 signaling. Rationale for combining DNMT and EZH2 inhibitors in colon cancer. Thankful to @theNCI and @ACS_Research for supporting our work! science.org/doi/10.1126/scia…
Scott Rothbart retweeted
Can't wait! 🔥🍹🍾
Excited to be organizing my first international conference w/@petertessarz @TheWebbLab & @Morrison_Lab_SU on #epigenetic & #aging & everything in between!
Amazing speakers (keynotes @BrunetLab @MAF_Dawson @OdedRechavi) & a new opportunity for trainees⬇️
events.faseb.org/event/a7662…
Scott Rothbart retweeted
New #Epigenetics review from the @RothbartLab! This paper highlights the significance of histone and non-histone lysine methylation signaling in skeletal muscle biology, spanning development, maintenance, regeneration, and disease progression. doi.org/10.1042/BCJ20230223
Scott Rothbart retweeted
In my PhD, I built an Epigenetics rooftop penthouse on my Bioengineering home. This combo led to interesting findings connecting lysine methylation with muscle physiology (out soon).
Today, I published with my mentor @RothbartLab a review talking about this scientific crossover.
Scott Rothbart retweeted
Please RT. NEW #GordonConference on "Histone and DNA Modifications" #epigenetics #chromatin 11-16. June 2023. Great speaker lineup. ➡️Register now grc.org/histone-and-dna-modi…
Scott Rothbart retweeted
With @RothbartLab and Josh Jang from @VAInstitute representing at #SU2CSummit2023 @SU2C – at California, USA




























